- Home
- PLX vs EBMT Comparison
PLX vs EBMT Comparison
Compare PLX & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- EBMT
- Stock Information
- Founded
- PLX 1993
- EBMT 1922
- Country
- PLX United States
- EBMT United States
- Employees
- PLX N/A
- EBMT N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- EBMT Major Banks
- Sector
- PLX Health Care
- EBMT Finance
- Exchange
- PLX Nasdaq
- EBMT Nasdaq
- Market Cap
- PLX 160.2M
- EBMT 141.1M
- IPO Year
- PLX 1998
- EBMT N/A
- Fundamental
- Price
- PLX $1.55
- EBMT $16.97
- Analyst Decision
- PLX Strong Buy
- EBMT
- Analyst Count
- PLX 1
- EBMT 0
- Target Price
- PLX $15.00
- EBMT N/A
- AVG Volume (30 Days)
- PLX 1.4M
- EBMT 44.6K
- Earning Date
- PLX 05-09-2025
- EBMT 07-22-2025
- Dividend Yield
- PLX N/A
- EBMT 3.36%
- EPS Growth
- PLX N/A
- EBMT 26.99
- EPS
- PLX 0.05
- EBMT 1.41
- Revenue
- PLX $59,764,000.00
- EBMT $82,271,000.00
- Revenue This Year
- PLX $65.02
- EBMT N/A
- Revenue Next Year
- PLX $57.34
- EBMT $4.97
- P/E Ratio
- PLX $32.18
- EBMT $12.04
- Revenue Growth
- PLX 0.18
- EBMT 0.06
- 52 Week Low
- PLX $0.82
- EBMT $12.61
- 52 Week High
- PLX $3.10
- EBMT $18.49
- Technical
- Relative Strength Index (RSI)
- PLX 30.03
- EBMT 44.41
- Support Level
- PLX $1.54
- EBMT $16.75
- Resistance Level
- PLX $1.79
- EBMT $17.35
- Average True Range (ATR)
- PLX 0.11
- EBMT 0.35
- MACD
- PLX -0.02
- EBMT -0.10
- Stochastic Oscillator
- PLX 27.27
- EBMT 14.97
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.